Tyra Biosciences (TYRA) Operating Expenses (2020 - 2026)

Tyra Biosciences' Operating Expenses history runs 7 years deep, the most recent figure standing at $42.0 million for Q1 2026.

• Quarterly Operating Expenses rose 31.86% year-over-year to $42.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $142.9 million (up 25.66% YoY) and the FY2025 annual result came in at $132.8 million, up 27.44% from the prior year.
• Operating Expenses was $42.0 million for Q1 2026 at Tyra Biosciences, up from $36.5 million in the prior quarter.
• Across five years, Operating Expenses topped out at $42.0 million in Q1 2026 and bottomed at $13.6 million in Q3 2022.
• A 5-year average of $24.6 million and a median of $24.0 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses jumped 252.27% — and 2023, when it slipped 3.37%.
• Tyra Biosciences' Operating Expenses stood at $15.0 million in 2022, then surged by 70.69% to $25.6 million in 2023, then gained by 16.03% to $29.7 million in 2024, then climbed by 22.77% to $36.5 million in 2025, then grew by 15.01% to $42.0 million in 2026.
• Business Quant data shows TYRA's Operating Expenses at $42.0 million in Q1 2026, $36.5 million in Q4 2025, and $32.9 million in Q3 2025.